These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 34055574)
1. Carbohydrate based biomarkers enable hybrid near infrared fluorescence and Wang W; Hansen AE; Sun H; Fliedner FP; Kjaer A; Jensen AI; Andresen TL; Henriksen JR Nanotheranostics; 2021; 5(4):448-460. PubMed ID: 34055574 [TBL] [Abstract][Full Text] [Related]
2. Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes. Carlos Dos Santos J; Beijer B; Bauder-Wüst U; Schäfer M; Leotta K; Eder M; Benešová M; Kleist C; Giesel F; Kratochwil C; Kopka K; Haberkorn U; Mier W J Nucl Med; 2020 Jan; 61(1):70-79. PubMed ID: 31541034 [TBL] [Abstract][Full Text] [Related]
3. A Pretargeted Approach for the Multimodal PET/NIRF Imaging of Colorectal Cancer. Adumeau P; Carnazza KE; Brand C; Carlin SD; Reiner T; Agnew BJ; Lewis JS; Zeglis BM Theranostics; 2016; 6(12):2267-2277. PubMed ID: 27924162 [TBL] [Abstract][Full Text] [Related]
4. What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between Bailly C; Gouard S; Guérard F; Chalopin B; Carlier T; Faivre-Chauvet A; Remaud-Le Saëc P; Bourgeois M; Chouin N; Rbah-Vidal L; Tripier R; Haddad F; Kraeber-Bodéré F; Bodet-Milin C; Chérel M Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137758 [TBL] [Abstract][Full Text] [Related]
5. A Modular Dual-Labeling Scaffold That Retains Agonistic Properties for Somatostatin Receptor Targeting. Ghosh SC; Rodriguez M; Carmon KS; Voss J; Wilganowski NL; Schonbrunn A; Azhdarinia A J Nucl Med; 2017 Nov; 58(11):1858-1864. PubMed ID: 28572490 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and Evaluation of 64Cu-DOTA-NT-Cy5.5 as a Dual-Modality PET/Fluorescence Probe to Image Neurotensin Receptor-Positive Tumor. Deng H; Wang H; Wang M; Li Z; Wu Z Mol Pharm; 2015 Aug; 12(8):3054-61. PubMed ID: 26162008 [TBL] [Abstract][Full Text] [Related]
7. Development of PEGylated peptide probes conjugated with (18)F-labeled BODIPY for PET/optical imaging of MT1-MMP activity. Kondo N; Temma T; Deguchi J; Sano K; Ono M; Saji H J Control Release; 2015 Dec; 220(Pt A):476-483. PubMed ID: 26578437 [TBL] [Abstract][Full Text] [Related]
8. Targeted Pretze M; van der Meulen NP; Wängler C; Schibli R; Wängler B J Labelled Comp Radiopharm; 2019 Jun; 62(8):471-482. PubMed ID: 30980411 [TBL] [Abstract][Full Text] [Related]
11. Radioactivity-synchronized fluorescence enhancement using a radionuclide fluorescence-quenched dye. Berezin MY; Guo K; Teng B; Edwards WB; Anderson CJ; Vasalatiy O; Gandjbakhche A; Griffiths GL; Achilefu S J Am Chem Soc; 2009 Jul; 131(26):9198-200. PubMed ID: 19514722 [TBL] [Abstract][Full Text] [Related]
12. (68)Ga/DOTA- and (64)Cu/NOTA-phthalocyanine conjugates as fluorescent/PET bimodal imaging probes. Ranyuk E; Lebel R; Bérubé-Lauzière Y; Klarskov K; Lecomte R; van Lier JE; Guérin B Bioconjug Chem; 2013 Sep; 24(9):1624-33. PubMed ID: 23978056 [TBL] [Abstract][Full Text] [Related]
13. Multimodal Nanocarrier Probes Reveal Superior Biodistribution Quantification by Isotopic Analysis over Fluorescence. Deng H; Konopka CJ; Cross TL; Swanson KS; Dobrucki LW; Smith AM ACS Nano; 2020 Jan; 14(1):509-523. PubMed ID: 31887006 [TBL] [Abstract][Full Text] [Related]
14. In vivo evaluation of PEGylated ⁶⁴Cu-liposomes with theranostic and radiotherapeutic potential using micro PET/CT. Petersen AL; Henriksen JR; Binderup T; Elema DR; Rasmussen PH; Hag AM; Kjær A; Andresen TL Eur J Nucl Med Mol Imaging; 2016 May; 43(5):941-952. PubMed ID: 26646780 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of a Fluorescent and Radiolabeled Hybrid Somatostatin Analog In Vitro and in Mice Bearing H69 Neuroendocrine Xenografts. Santini C; Kuil J; Bunschoten A; Pool S; de Blois E; Ridwan Y; Essers J; Bernsen MR; van Leeuwen FW; de Jong M J Nucl Med; 2016 Aug; 57(8):1289-95. PubMed ID: 27127222 [TBL] [Abstract][Full Text] [Related]
16. uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: proof-of-concept in orthotopic xenograft model. Christensen A; Juhl K; Persson M; Charabi BW; Mortensen J; Kiss K; Lelkaitis G; Rubek N; von Buchwald C; Kjær A Oncotarget; 2017 Feb; 8(9):15407-15419. PubMed ID: 28039488 [TBL] [Abstract][Full Text] [Related]
17. ImmunoPET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer with a Dual-Labeled Bispecific Antibody Fragment. Luo H; England CG; Goel S; Graves SA; Ai F; Liu B; Theuer CP; Wong HC; Nickles RJ; Cai W Mol Pharm; 2017 May; 14(5):1646-1655. PubMed ID: 28292180 [TBL] [Abstract][Full Text] [Related]
18. Integrin α Shi X; Shen L J Inorg Biochem; 2018 Sep; 186():257-263. PubMed ID: 29990749 [TBL] [Abstract][Full Text] [Related]
19. Targeting MMP-14 for dual PET and fluorescence imaging of glioma in preclinical models. Kasten BB; Jiang K; Cole D; Jani A; Udayakumar N; Gillespie GY; Lu G; Dai T; Rosenthal EL; Markert JM; Rao J; Warram JM Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1412-1426. PubMed ID: 31773232 [TBL] [Abstract][Full Text] [Related]
20. Preclinical Evaluation of a High-Affinity Sarcophagine-Containing PSMA Ligand for Kelly JM; Ponnala S; Amor-Coarasa A; Zia NA; Nikolopoulou A; Williams C; Schlyer DJ; DiMagno SG; Donnelly PS; Babich JW Mol Pharm; 2020 Jun; 17(6):1954-1962. PubMed ID: 32286841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]